These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 9208379)

  • 21. [Deficit schizophrenia: from pharmacology to clinical practice].
    Tassin JP
    Encephale; 1996 Jun; 22 Spec No 2():9-12. PubMed ID: 8767035
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dopamine, the prefrontal cortex and schizophrenia.
    Knable MB; Weinberger DR
    J Psychopharmacol; 1997; 11(2):123-31. PubMed ID: 9208376
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence for co-release of noradrenaline and dopamine from noradrenergic neurons in the cerebral cortex.
    Devoto P; Flore G; Pani L; Gessa GL
    Mol Psychiatry; 2001 Nov; 6(6):657-64. PubMed ID: 11673793
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Subchronic milnacipran treatment increases basal extracellular noradrenaline concentrations in the medial prefrontal cortex of rats.
    Kitaichi Y; Inoue T; Izumi T; Nakagawa S; Kato A; Koyama T
    Eur J Pharmacol; 2005 Sep; 520(1-3):37-42. PubMed ID: 16153636
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel pharmacological approaches to the treatment of schizophrenia.
    Fink-Jensen A
    Dan Med Bull; 2000 Jun; 47(3):151-67. PubMed ID: 10913983
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Noradrenergic modulation of cognitive function in rat medial prefrontal cortex as measured by attentional set shifting capability.
    Lapiz MD; Morilak DA
    Neuroscience; 2006 Feb; 137(3):1039-49. PubMed ID: 16298081
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selective action of acute systemic clozapine on acetylcholine release in the rat prefrontal cortex by reference to the nucleus accumbens and striatum.
    Parada MA; Hernandez L; Puig de Parada M; Rada P; Murzi E
    J Pharmacol Exp Ther; 1997 Apr; 281(1):582-8. PubMed ID: 9103547
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Co-release of noradrenaline and dopamine in the prefrontal cortex after acute morphine and during morphine withdrawal.
    Devoto P; Flore G; Pira L; Diana M; Gessa GL
    Psychopharmacology (Berl); 2002 Mar; 160(2):220-4. PubMed ID: 11875641
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Flibanserin, a potential antidepressant drug, lowers 5-HT and raises dopamine and noradrenaline in the rat prefrontal cortex dialysate: role of 5-HT(1A) receptors.
    Invernizzi RW; Sacchetti G; Parini S; Acconcia S; Samanin R
    Br J Pharmacol; 2003 Aug; 139(7):1281-8. PubMed ID: 12890707
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term effects of JL 13, a potential atypical antipsychotic, on rat dopamine and serotonin receptor subtypes.
    Moran-Gates T; Massari C; Graulich A; Liégeois JF; Tarazi FI
    J Neurosci Res; 2006 Aug; 84(3):675-82. PubMed ID: 16810690
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of the locus coeruleus-limbic noradrenergic transmission in the action of antidepressant drugs.
    Kostowski W; Plaźnik A; Danysz W
    Psychopharmacol Bull; 1986; 22(2):512-22. PubMed ID: 3022322
    [No Abstract]   [Full Text] [Related]  

  • 32. [Quetiapin in bipolar disorders].
    Sümegi A
    Neuropsychopharmacol Hung; 2008 Dec; 10(5):281-91. PubMed ID: 19419014
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The atypical antipsychotic drug clozapine enhances chronic PCP-induced regulation of prefrontal cortex 5-HT2A receptors.
    Steward LJ; Kennedy MD; Morris BJ; Pratt JA
    Neuropharmacology; 2004 Sep; 47(4):527-37. PubMed ID: 15380371
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dynamic regulation of glutamatergic postsynaptic activity in rat prefrontal cortex by repeated administration of antipsychotic drugs.
    Fumagalli F; Frasca A; Racagni G; Riva MA
    Mol Pharmacol; 2008 May; 73(5):1484-90. PubMed ID: 18250147
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of noradrenergic transmission in the mechanism of action of classical and novel antidepressant drugs.
    Langer SZ; Graham D; Pimoule C; Arbilla S
    Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():317A-318A. PubMed ID: 1323394
    [No Abstract]   [Full Text] [Related]  

  • 36. alpha2-Noradrenergic receptors activation enhances excitability and synaptic integration in rat prefrontal cortex pyramidal neurons via inhibition of HCN currents.
    Carr DB; Andrews GD; Glen WB; Lavin A
    J Physiol; 2007 Oct; 584(Pt 2):437-50. PubMed ID: 17702809
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aripiprazole, a novel antipsychotic drug, preferentially increases dopamine release in the prefrontal cortex and hippocampus in rat brain.
    Li Z; Ichikawa J; Dai J; Meltzer HY
    Eur J Pharmacol; 2004 Jun; 493(1-3):75-83. PubMed ID: 15189766
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential effects of M1 and 5-hydroxytryptamine1A receptors on atypical antipsychotic drug-induced dopamine efflux in the medial prefrontal cortex.
    Li Z; Prus AJ; Dai J; Meltzer HY
    J Pharmacol Exp Ther; 2009 Sep; 330(3):948-55. PubMed ID: 19491322
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of the glycine transporter GlyT-1 potentiates the effect of risperidone, but not clozapine, on glutamatergic transmission in the rat medial prefrontal cortex.
    Konradsson A; Marcus MM; Hertel P; Svensson TH; Jardemark KE
    Synapse; 2006 Aug; 60(2):102-8. PubMed ID: 16715496
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clozapine decreases exploratory activity and increases anxiety-like behaviour in the Wistar-Kyoto rat but not the spontaneously hypertensive rat model of attention-deficit/hyperactivity disorder.
    Mc Fie S; Sterley TL; Howells FM; Russell VA
    Brain Res; 2012 Jul; 1467():91-103. PubMed ID: 22658977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.